What does Exphar do?
Exphar is a company specializing in the development and production of pharmaceutical products. It focuses on providing innovative solutions for the healthcare industry, including medication for various medical needs. The company is dedicated to ensuring high-quality standards and compliance with regulatory requirements.
- Sectors
- Wholesalers
- Signals
-
ProfitableProfitable € 868K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 5.54MStrong equity provides a buffer against setbacks.
Low riskLow risk 39.2%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.52A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 1.50MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 2.06MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 22.88MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 16.6%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
22.88M
|
€
22.41M
|
€
20.92M
|
€
21.05M
|
|
|
€
2.06M
|
€
1.52M
|
€
3.25M
|
€
2.74M
|
|
|
€
868K
|
€
397K
|
€
1.15M
|
€
987K
|
|
|
€
5.54M
|
€
4.70M
|
€
4.26M
|
€
6.52M
|
|
|
39.21%
|
29.06%
|
24.41%
|
39.03%
|
|
|
€
8.50M
|
€
11.37M
|
€
13.07M
|
€
9.86M
|
|
|
€
1.75M
|
€
1.96M
|
€
1.03M
|
€
473K
|
|
|
26.10
|
26.00
|
19.00
|
16.00
|
Publications 59
All publications- Demissions, Nominations 01/08/2025
- Demissions, Nominations 15/07/2024
- Demissions, Nominations 08/08/2023
- Demissions, Nominations 06/03/2023
- Demissions, Nominations 03/01/2023
Frequently asked questions
Answers to the most common questions about Exphar, based on official government data and the filed annual accounts.
What is the VAT number of Exphar?
The VAT number of Exphar is BE0421.802.718.
How many employees work at Exphar?
In 2025, Exphar employed 26.10 full-time equivalents (FTE).
When was Exphar established?
Exphar was founded in 27-08-1981.
What is the official address of Exphar?
The official address of Exphar is Avenue Thomas Edison 105 Nivelles 1402.
What is the legal form of Exphar?
The juridical form of Exphar is Public limited company (NV/SA).
What is the annual revenue of Exphar?
The revenue of Exphar for the 2025 financial year was €22,881,746.
What does Exphar do?
Exphar is a company specializing in the development and production of pharmaceutical products. It focuses on providing innovative solutions for the healthcare industry, including medication for various medical needs. The company is dedicated to ensuring high-quality standards and compliance with regulatory requirements.
Is Exphar a reliable company?
Exphar is a registered Rechtspersoon with company number 0421.802.718 and can be verified through the official CBE database.
What is the credit limit of Exphar?
The estimated credit limit of Exphar is €3,612,780.
Is Exphar still active?
Exphar currently has the status "Normal situation" and is active.